1. Home
  2. TNGX vs CAN Comparison

TNGX vs CAN Comparison

Compare TNGX & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • CAN
  • Stock Information
  • Founded
  • TNGX 2014
  • CAN 2013
  • Country
  • TNGX United States
  • CAN Singapore
  • Employees
  • TNGX N/A
  • CAN N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • TNGX Health Care
  • CAN Technology
  • Exchange
  • TNGX Nasdaq
  • CAN Nasdaq
  • Market Cap
  • TNGX 413.6M
  • CAN 425.9M
  • IPO Year
  • TNGX N/A
  • CAN 2019
  • Fundamental
  • Price
  • TNGX $3.04
  • CAN $2.25
  • Analyst Decision
  • TNGX Strong Buy
  • CAN Strong Buy
  • Analyst Count
  • TNGX 8
  • CAN 3
  • Target Price
  • TNGX $13.14
  • CAN $3.00
  • AVG Volume (30 Days)
  • TNGX 1.5M
  • CAN 24.8M
  • Earning Date
  • TNGX 11-06-2024
  • CAN 11-20-2024
  • Dividend Yield
  • TNGX N/A
  • CAN N/A
  • EPS Growth
  • TNGX N/A
  • CAN N/A
  • EPS
  • TNGX N/A
  • CAN N/A
  • Revenue
  • TNGX $43,383,000.00
  • CAN $229,630,000.00
  • Revenue This Year
  • TNGX $27.73
  • CAN $24.51
  • Revenue Next Year
  • TNGX N/A
  • CAN $84.90
  • P/E Ratio
  • TNGX N/A
  • CAN N/A
  • Revenue Growth
  • TNGX 15.67
  • CAN N/A
  • 52 Week Low
  • TNGX $2.70
  • CAN $0.72
  • 52 Week High
  • TNGX $13.01
  • CAN $3.50
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 39.30
  • CAN 49.90
  • Support Level
  • TNGX $2.72
  • CAN $2.01
  • Resistance Level
  • TNGX $3.29
  • CAN $3.27
  • Average True Range (ATR)
  • TNGX 0.30
  • CAN 0.38
  • MACD
  • TNGX 0.07
  • CAN -0.10
  • Stochastic Oscillator
  • TNGX 32.08
  • CAN 19.05

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

Share on Social Networks: